Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors-Reference-Cited by-同舟云学术

Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors

Published:2018-05-08 Issue:21 Volume:10 Page:17672-17684
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Wei Xiao,Liu Lingqiao,Guo Xing,Wang Yi,Zhao Jingya,Zhou Shaobing^ORCID

Funder

National Natural Science Foundation of China

Sichuan Province

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.8b04163

Reference53 articles.

1. Targeting multidrug resistance in cancer

2. MSN Anti-Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition

3. Mechanisms of Drug Resistance in Cancer Chemotherapy

4. Enhanced Chemotherapy of Cancer Using pH-Sensitive Mesoporous Silica Nanoparticles to Antagonize P-Glycoprotein–Mediated Drug Resistance

5. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Things to Know and Latest Trends in the Design and Application of Nanoplatforms in Cancer Treatment;BioNanoScience;2024-08-12

2. Tailor-Made Polysaccharides for Biomedical Applications;ACS Applied Bio Materials;2024-07-03

3. Coordination bonded stimuli-responsive drug delivery system of chemical actives with metal in pharmaceutical applications;Coordination Chemistry Reviews;2024-07

4. The Pharmaceutical Role of Silver Nanoparticles in Treating Multidrug- Resistant Bacteria and Biofilms;Current Nanoscience;2024-07

5. Progress and promise of photoresponsive nanocarriers for precision drug delivery in cancer;Journal of Photochemistry and Photobiology C: Photochemistry Reviews;2024-06